139 related articles for article (PubMed ID: 28982856)
1.
Tarrini G; Ciabatti E; Pacini S; Galimberti S; Petrini I
Anticancer Res; 2017 Oct; 37(10):5459-5462. PubMed ID: 28982856
[TBL] [Abstract][Full Text] [Related]
2. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
3. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
Petrini I; Meltzer PS; Kim IK; Lucchi M; Park KS; Fontanini G; Gao J; Zucali PA; Calabrese F; Favaretto A; Rea F; Rodriguez-Canales J; Walker RL; Pineda M; Zhu YJ; Lau C; Killian KJ; Bilke S; Voeller D; Dakshanamurthy S; Wang Y; Giaccone G
Nat Genet; 2014 Aug; 46(8):844-9. PubMed ID: 24974848
[TBL] [Abstract][Full Text] [Related]
4. A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
He Y; Kim IK; Bian J; Polyzos A; Di Giammartino DC; Zhang YW; Luo J; Hernandez MO; Kedei N; Cam M; Borczuk AC; Lee T; Han Y; Conner EA; Wong M; Tillo DC; Umemura S; Chen V; Ruan L; White JB; Miranda IC; Awasthi PP; Altorki NK; Divakar P; Elemento O; Apostolou E; Giaccone G
J Thorac Oncol; 2022 Dec; 17(12):1375-1386. PubMed ID: 36049655
[TBL] [Abstract][Full Text] [Related]
5. Gene of the month:
Nathany S; Tripathi R; Mehta A
J Clin Pathol; 2021 Jan; 74(1):1-4. PubMed ID: 32907914
[TBL] [Abstract][Full Text] [Related]
6. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
7. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
9. Unique correlation between GTF2I mutation and spindle cell morphology in thymomas (type A and AB thymomas).
Wells K; Lamrca A; Papaxoinis G; Wallace A; Quinn AM; Summers Y; Nonaka D
J Clin Pathol; 2023 Jul; 76(7):463-466. PubMed ID: 35039450
[TBL] [Abstract][Full Text] [Related]
10. Acute leukemia: a pediatric perspective.
Downing JR; Shannon KM
Cancer Cell; 2002 Dec; 2(6):437-45. PubMed ID: 12498712
[TBL] [Abstract][Full Text] [Related]
11. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
[TBL] [Abstract][Full Text] [Related]
12. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
Hernández JM; Granada I; Solé F;
Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
[TBL] [Abstract][Full Text] [Related]
13. p53 gene alterations in human hematological malignancies: a review.
Soussi T; Jonveaux P
Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
15. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
16. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas.
Hsieh MS; Kao HL; Huang WC; Wang SY; Lin SY; Chu PY; Pan CC; Chou TY; Ho HL; Yeh YC
Mod Pathol; 2023 Feb; 36(2):100008. PubMed ID: 36853782
[TBL] [Abstract][Full Text] [Related]
17. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
Jain D; Guleria P; Singh V; Parshad R; Kumar S; Gaiser T; Kurz KS; Ott G; Porubsky S; Preissler G; Sauer CG; Schölch S; Ströbel P; Hielscher T; Marx A; Popovic ZV
Pathol Oncol Res; 2021; 27():1609858. PubMed ID: 34497477
[TBL] [Abstract][Full Text] [Related]
18. [Studies on CFU-Mix in 54 cases of leukemia and myelodysplastic syndrome].
Chen Y; Wang BM; Li CY
Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):35-8, 62-3. PubMed ID: 2737036
[TBL] [Abstract][Full Text] [Related]
19. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
[TBL] [Abstract][Full Text] [Related]
20. c-Src activation through a TrkA and c-Src interaction is essential for cell proliferation and hematological malignancies.
Kim MS; Kim GM; Choi YJ; Kim HJ; Kim YJ; Jin W
Biochem Biophys Res Commun; 2013 Nov; 441(2):431-7. PubMed ID: 24369899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
